Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Apr;22(4):664–672. doi: 10.1681/ASN.2010060594

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2011 by the American Society of Nephrology

PMC Copyright notice

Figure 1. — COX2 is expressed in the hyperplastic PTGs from hemodialysis patients. (A) COX2 immunoreactivity in PTGs with diffuse hyperplasia (A1, A4), early nodular hyperplasia (A2, A5), and nodular hyperplasia (A3, A6). Magnifications: ×5 in A1 through A3; ×400 in A4 through A6. (B) Immunoblot of diffuse hyperplasia and nodular hyperplasia PTGs using antibodies for COX2 and β-actin as a loading control. Quantitative analysis result was expressed as COX2/β-actin protein ratio. ^bP < 0.01 versus diffuse hyperplasia tissue.